Home » Cabozantinib and nivolumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial
Cabozantinib and nivolumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial
by Roodhooft, I., Kinget, L., Mammone, G., Baldewijns, M., Debruyne, PR, Roussel, E., Albersen, M., Demeulenaere, O., Garg, AD, Clement, PM, Van Loon, J., De Vleeschouwer, S., Van Den Bulck, H., Vandermeulen, H., De Wever, L., Laerte, A. & Beuselinck, B. | Mar 7, 2026 | Articles |
